Valuation Sun Pharmaceutical Industries Ltd.

Stocks

Market Closed - NSE India S.E. 15:22:05 30/10/2026 +03			5-day change	1st Jan Change
1,777.70 ^INR	+0.95%		+1.70%	+3.37%

10-30	Sun Pharmaceutical Industries Limited Announces FDA Approval Of ILUMYA For Treatment Of Adults With Active Psoriatic Arthritis	CI
10-30	Sun Pharmaceutical Industries Limited, Q2 2027 Earnings Call, Oct 30, 2026

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	2,194,737	2,358,729	3,888,242	4,162,126	4,216,111	4,265,298	-	-
Change	-	7.47%	64.84%	7.04%	1.3%	1.17%	-	-
Enterprise Value (EV) ¹	2,077,371	2,269,278	3,725,634	3,930,920	3,931,562	4,029,463	3,936,681	3,866,197
Change	-	9.24%	64.18%	5.51%	0.02%	2.49%	-2.3%	-1.79%
P/E	67.3x	27.8x	40.6x	38x	36.8x	36.9x	27.9x	24.3x
PBR	4.57x	4.21x	6.11x	5.76x	5.04x	4.82x	4.16x	3.72x
PEG	-	0x	3.1x	2.7x	7.63x	46.63x	0.9x	1.7x
Capitalization / Revenue	5.68x	5.37x	8.02x	7.92x	7.21x	6.55x	5.85x	5.27x
EV / Revenue	5.37x	5.17x	7.68x	7.48x	6.72x	6.19x	5.4x	4.78x
EV / EBITDA	20x	19.5x	28.7x	26.1x	23.8x	22x	18.1x	15.6x
EV / EBIT	25.2x	24.9x	35.7x	31.4x	29x	26.3x	21.6x	18.3x
EV / FCF	27.7x	79x	37.5x	32.9x	44.6x	69.2x	29.3x	24.5x
FCF Yield	3.61%	1.27%	2.67%	3.04%	2.24%	1.45%	3.41%	4.08%
Dividend per Share ²	10	11.5	13.5	16	16	16.81	19.87	21.15
Rate of return	1.09%	1.17%	0.83%	0.92%	0.91%	0.95%	1.12%	1.19%
EPS ²	13.6	35.3	39.9	45.6	47.8	48.18	63.72	73.04
Distribution rate	73.5%	32.6%	33.8%	35.1%	33.5%	34.9%	31.2%	29%
Net sales ¹	386,545	438,857	484,968	525,784	584,620	651,000	728,711	808,948
EBITDA ¹	103,977	116,468	129,870	150,862	164,912	183,335	217,916	247,908
EBIT ¹	82,540	91,174	104,304	125,108	135,534	153,306	182,058	211,774
Net income ¹	32,727	84,736	95,764	109,290	114,794	129,581	154,189	176,757
Net Debt ¹	-117,366	-89,450	-162,609	-231,206	-284,549	-235,835	-328,616	-399,101
Reference price ²	914.75	983.10	1,620.55	1,734.70	1,757.20	1,777.70	1,777.70	1,777.70
Nbr of stocks (in thousands)	2,399,276	2,399,276	2,399,335	2,399,335	2,399,335	2,399,335	-	-
Announcement Date	5/30/22 A	5/26/23 A	5/22/24 A	5/22/25 A	5/22/26 A	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	33.17x	6.1x	21.19x	0.96%	44.92B
ELI LILLY AND COMPANY	41.54x	14.06x	31.11x	0.48%	1,263B
JOHNSON & JOHNSON	39.99x	6.71x	18.89x	1.95%	658B
ABBVIE INC.	38.61x	8.62x	17.83x	2.33%	521B
ROCHE HOLDING AG	21.74x	5.27x	13.12x	2.48%	391B
MERCK & CO., INC.	109.15x	6.06x	25.73x	2.28%	369B
NOVARTIS AG	23.19x	5.97x	14.41x	2.71%	307B
ASTRAZENECA PLC	24.47x	4.9x	13.63x	1.77%	290B
AMGEN INC.	29.56x	7.53x	13.48x	2.16%	252B
GILEAD SCIENCES, INC.	-49.1x	7.47x	29.35x	1.93%	212B
Average	31.23x	7.27x	19.87x	1.91%	430.68B
Weighted average by Cap.	37.24x	8.81x	21.95x	1.68%